What does the DAIDS/RSC Regulatory team do?

The Regulatory Team reviews Protocol Documents for regulatory compliance, and prepares and files new Investigation New Drug Applications (INDs) and amendments to existing INDs in compliance with the procedural and substantive requirements of 21 CFR § 312. Examples of submissions to the FDA include original IND Applications, Annual Reports, Safety Reports, and Responses to FDA Requests for Information.